Positive Predictive Value for Multitarget Stool DNA After Bariatric and Metabolic Surgery

Positive Predictive Value for Multitarget Stool DNA After Bariatric and Metabolic Surgery

Background and Aims: Bariatric and metabolic surgery (BMS) may adversely affect noninvasive stool tests for colorectal cancer (CRC) screening through several mechanisms. Multitarget stool DNA (mt-sDNA) is approved for CRC screening; however, performance in post-BMS patients is unknown. As the rates...

Full description

Bibliographic Details
Main Authors: Derek W. Ebner, Kelli N. Burger, Brendan Broderick, Douglas W. Mahoney, Todd A. Kellogg, Andres Acosta, John B. Kisiel
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Gastro Hep Advances
Subjects:
Bariatric and Metabolic Surgery
Colorectal Neoplasms/Prevention and Control
DNA Methylation
Colonoscopy
Online Access:http://www.sciencedirect.com/science/article/pii/S2772572323000912

Internet

http://www.sciencedirect.com/science/article/pii/S2772572323000912

Similar Items